“Project IMPACT: Diabetes” Care Model Improves Health Outcomes in Underserved Populations in 25 Communities with a High Incidence of Diabetes

November/December 2013, Vol 6, No 9 - Industry Trends
Benjamin M. Bluml, RPh
Senior Vice President for Research and Innovation
American Pharmacists Association Foundation
Washington, DC
Download PDF

Chronic disease is responsible for 7 of 10 deaths in the United States and 75% of the nation’s $2.2-trillion healthcare bill.1,2 According to the American Diabetes Association, nearly 26 million Americans have diabetes, and more than 200,000 die of this chronic disease annually. Patients with diabetes are at increased risk for diabetes-related complications, includ­ing heart disease, stroke, kidney failure, blindness, and lower-limb amputations.3

In 2010, the Bristol-Myers Squibb (BMS) Foundation announced the establishment of Together on Diabetes—a 5-year, $100-million initiative designed to improve the health outcomes of underserved patients with type 2 diabetes in the United States, China, and India.

One of the first 4 organizations in the BMS Foundation’s Together on Diabetes, the American Pharmacists Association (APhA) Foundation received a grant from the BMS Foundation to launch “Project IMPACT: Diabetes,” to bring quality care to underserved people in 25 US communities with a high incidence of diabetes.

Project IMPACT: Diabetes
The objectives of Project IMPACT: Diabetes are to expand the proven community-based model of care to patients who need it the most in communities across the United States, to improve key indicators of diabetes care in these selected communities, and to strengthen local models of care by establishing community peer-to-peer networking and mentoring relationships.

Organizations selected to participate in Project IMPACT: Diabetes include community and university-­affiliated pharmacies, self-insured employers, federally qualified health centers, free health clinics, and others that have the opportunity to leverage unique stakeholders, existing programs, creative ideas, and additional resources to effectively adapt and implement similar models of care. The APhA Foundation also provides communities with tools, resources, guidance, and support to facilitate local success.

The APhA Foundation educates each community about this care model that places the patient with diabetes on the healthcare team, and inserts the pharmacist as a valued health coach. The Foundation also provides training and access to the Patient Self-Management Credential for Diabetes and a clinical data management tool, which are core components of the project.

The clinical data management tool standardized the data set that all 25 communities are collecting throughout the project. The APhA Foundation’s Patient Self-Management Credential for diabetes helps pharmacists identify the patient’s knowledge strengths and areas for improvement, allowing providers to customize the patient’s education and to address the biggest knowledge gaps first. Pharmacists are also able to use each patient’s credential level to recognize achievements in diabetes self-management knowledge, skills, and performance.

Through Project IMPACT: Diabetes, more than 2000 underserved patients, including those who are uninsured, underinsured, homeless, and/or living below the poverty line are currently receiving care from community-based interdisciplinary teams that include pharmacists, physicians, diabetes educators, and other healthcare professionals.

The cornerstone of local implementations is one-on-one patient consultations with pharmacists trained in diabetes care who monitor the patients’ A1c level, blood pressure, cholesterol, and body mass index, and help patients to manage their disease through appropriate medication use, exercise, nutrition, and other lifestyle changes. Pharmacists collaborate with and refer patients to physicians and other healthcare providers to ensure that patients receive comprehensive care.

In addition, the communities are encouraged to incentivize patients to stay motivated about diabetes self-management. Some incentives include bus passes, food store gift cards, discounted or free healthy lunches at employer worksites, discounted copayments, or simply the ability to continue to have a healthcare provider focus on helping the patient.

Interim Results
Project IMPACT: Diabetes has scaled previous APhA Foundation collaborative care programs for the selected 25 communities. Over a mean duration of 6 months, healthcare teams saw statistically significant improvements in the diabetes-related clinical outcomes of their patients (Table), including an overall reduction in A1c levels from 9.0% to 8.3%; a 7.3-mg/dL reduction in low-density lipoprotein cholesterol; and a 1.9-mm Hg reduction in systolic blood pressure.4 Dramatic improvements were also seen in patients’ ability to manage their diabetes, in large part as a result of the adaptability of the care model to fit local needs.


Table

Conclusion
Every patient with diabetes faces challenges, such as adhering to prescribed medications, monitoring blood glucose levels, staying current with vaccines and foot and eye examinations, and maintaining a healthy diet and lifestyle. This initiative shows that all types of patients with diabetes, including the poor and uninsured, by working together with pharmacists and other members of the healthcare team, can be empowered to take the steps they need to understand and manage their diabetes. The interim results of Project IMPACT: Diabetes demonstrate that when patients are supported and empowered to make the lifestyle changes that are necessary to manage a chronic disease such as diabetes, significant improvements are possible. It is an idea whose time has come.

Author Disclosure Statement
Mr Bluml is an employee of the APhA Foundation.

References
  1. Centers for Disease Control and Prevention. Chronic diseases and health promotion. Updated August 13, 2012. Reviewed August 13, 2012. www.cdc.gov/chronicdisease/overview/index.htm. Accessed November 26, 2013.
  2. Centers for Disease Control and Prevention. Chronic diseases: the power to prevent, the call to control: at a glance 2009.
  3. www.cdc.gov/chronicdisease/resources/publications/aag/pdf/chronic.pdf. Accessed November 26, 2013.
  4. American Diabetes Association. Diabetes statistics. Reviewed June 6, 2013. www.diabetes.org/diabetes-basics/diabetes-statistics/. Accessed November 26, 2013.
  5. American Pharmacists Association Foundation. Project IMPACT: Diabetes: the results. www.aphafoundation.org/project-impact-diabetes/results. Accessed November 26, 2013.
Related Items
Value-Based Agreements in Healthcare: Willingness versus Ability
Gary Branning, MBA, Michael Lynch, CPA, MBA, Kathryn Hayes
September 2019 Vol 12, No 5 published on September 17, 2019 in Industry Trends
US Healthcare Trends and Contradictions in 2019
F. Randy Vogenberg, PhD
February 2019 Vol 12, No 1 published on February 6, 2019 in Industry Trends
A Shift in Party Majority, a Shift in Priority? What the Pharmaceutical Industry Can Expect
Gary Branning, MBA, Randy Ross, BA, Kathryn Hayes
February 2019 Vol 12, No 1 published on February 6, 2019 in Industry Trends
FDA Commissioner Outlines New Plan to Increase Biosimilars by Balancing Innovation and Competition
Eileen Koutnik-Fotopoulos
November 2018 Vol 11, No 8 published on November 30, 2018 in Industry Trends
New Rivals: Integrating Health Benefits to Provide Comprehensive Patient Care
Gary Branning, MBA, Martha Vater
April 2018 Vol 11, No 2 published on April 13, 2018 in Industry Trends
Last modified: December 16, 2013
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME